Essential Steps to Successful Biopharma Partnering
Preparing Your Company for the M&A Process
The Art & Science of High M&A Valuation
Best Practices for Fundraising and M&A Due Diligence
This whitepaper explores the importance of establishing early goals and objectives for the process, how to get the right people to ask the right questions in advance of the process, how to build credibility by defining goals and demonstrating they can be achieved, and much more.
Getting Ready for a Biopharma Partnering Deal
Demystifying Tech M&A Valuation
This whitepaper shares the most common scenarios that arise when you are selling your company, the choices you have when negotiating the terms of the sale, and which choices are your best ones, as supported by academic research are covered.
The Nuts & Bolts of Due Diligence in Biopharma Partnering
How to Win at the Partnering Game
In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy.
Earnouts: Structures for Breaking Negotiation Deadlocks
This white paper features Senior M&A Executive Javier Enrile of Principal Global Investors. Mr. Enrile provides his extensive expertise to explain how earnout, (also "earn-out") structures work and how it can reduce risk for the buyer, add attractive incentives for the seller, and serve to break negotiation deadlocks and get deals consummated.
The $800 Billion Global Packaging Industry: Trends in M&A in 2018
M&A Integration‚ Maximizing the Return on Technology and Talent